![]() |
|
|
Vol. 54, Issue 6, 1106-1112, December 1998
Georgetown University Medical Center, Department of Pharmacology,
Washington, DC 20007
A human recombinant L-type Ca2+ channel
(
1C,77) was coexpressed with the rat angiotensin
AT1A receptor in Xenopus laevis oocytes. In
oocytes expressing only
1C,77 channels, application of
human angiotensin II (1-10 µM) did not affect the
amplitude or kinetics of Ba2+ currents (IBa).
In sharp contrast, in oocytes coexpressing
1C,77 channels and AT1A receptors, application of 1 nM to 1 µM angiotensin gradually and
reversibly inhibited IBa, without significantly changing
its kinetics. The inhibitory effect of angiotensin on IBa
was abolished in oocytes that had been preincubated with losartan (an
AT1A receptor antagonist) or thapsigargin or injected with 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetate,
pertussis toxin, guanosine-5'-O-(2-thio)diphosphate, or
heparin, suggesting that the recombinant
1C channels
were regulated by angiotensin through G protein-coupled
AT1A receptors via activation of the inositol
trisphosphate-dependent intracellular Ca2+ release pathway.
Consistent with this hypothesis, no cross-signaling occurred between
the AT1A receptor and a splice variant of
1C lacking Ca2+ sensors (
1C,86). The data
suggest that the regulation of recombinant L-type Ca2+
channels by angiotensin is mediated by inositol trisphosphate-induced intracellular Ca2+ release and occurs at the molecular
motif responsible for the Ca2+-induced inactivation of the channels.
This article has been cited by other articles:
![]() |
M. Oz, K.-H. Yang, M. Dinc, and T. S. Shippenberg The Endogenous Cannabinoid Anandamide Inhibits Cromakalim-Activated K+ Currents in Follicle-Enclosed Xenopus Oocytes J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 547 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oz, S. N. Jackson, A. S. Woods, M. Morales, and L. Zhang Additive Effects of Endogenous Cannabinoid Anandamide and Ethanol on {alpha}7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1272 - 1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oz, L. Zhang, A. Ravindran, M. Morales, and C. R. Lupica Differential Effects of Endogenous and Synthetic Cannabinoids on {alpha}7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1152 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Weiss, T. Doan, K. E. Bernstein, and N. Dascal Modulation of Cardiac Ca2+ Channel by Gq-activating Neurotransmitters Reconstituted in Xenopus Oocytes J. Biol. Chem., March 26, 2004; 279(13): 12503 - 12510. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oz, A. Ravindran, O. Diaz-Ruiz, L. Zhang, and M. Morales The Endogenous Cannabinoid Anandamide Inhibits {alpha}7 Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 1003 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Abernethy and N. M. Soldatov Structure-Functional Diversity of Human L-Type Ca2+ Channel: Perspectives for New Pharmacological Targets J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 724 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Kamatchi, M. E. Durieux, and C. Lynch III Differential Sensitivity of Expressed L-Type Calcium Channels and Muscarinic M1 Receptors to Volatile Anesthetics in Xenopus Oocytes J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 981 - 990. [Abstract] [Full Text] |
||||
![]() |
D. C. Bell, A. J. Butcher, N. S. Berrow, K. M. Page, P. F. Brust, A. Nesterova, K. A. Stauderman, G. R. Seabrook, B. Nurnberg, and A. C. Dolphin Biophysical Properties, Pharmacology, and Modulation of Human, Neuronal L-Type ({alpha}1D, CaV1.3) Voltage-Dependent Calcium Currents J Neurophysiol, February 1, 2001; 85(2): 816 - 827. [Abstract] [Full Text] [PDF] |
||||